Skip to main content
PegBio Co., Ltd. logo

PegBio Co., Ltd. — Investor Relations & Filings

Ticker · 2565 ISIN · CNE100006T44 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 2,125 across all filing types
Latest filing 2020-11-02 Regulatory Filings
Country HK Hong Kong
Listing HKEX 2565

About PegBio Co., Ltd.

http://www.pegbio.com

PegBio Co., Ltd. is a biotechnology company specializing in the in-house discovery and development of innovative therapies for chronic diseases, primarily focusing on the endocrine and metabolic fields. The company leverages its proprietary HECTORTM technology system to design and screen novel molecular entities, including peptide, protein, and small-molecule drugs, targeting unmet clinical needs. PegBio's robust pipeline addresses major chronic conditions such as Type 2 Diabetes (T2DM), obesity, and metabolic dysfunction-associated steatohepatitis (MASH). Key pipeline assets include long-acting GLP-1 receptor agonists, such as Vepinatide, developed for T2DM treatment and weight management. The company emphasizes creating complementary, multi-benefit product pipelines characterized by new targets, new sites, and new mechanisms of action.

Recent filings

Filing Released Lang Actions
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2020
Regulatory Filings Classification · 95% confidence The document is a detailed monthly report on movements in securities, specifically focusing on changes in authorised and issued share capital, share options, warrants, convertibles, and other share-related transactions for CMBC Capital Holdings Limited. It includes data on share repurchases, cancellations, and confirmations related to share issuance. The document is addressed to the Hong Kong Exchanges and Clearing Limited and is dated for the month ended 31/10/2020. This type of document is a regulatory filing that reports on share capital movements and related corporate actions but does not constitute a full financial report, earnings release, or management discussion. It is not an announcement of voting results, board changes, or a capital raising update per se, but rather a formal regulatory disclosure of share capital movements. Therefore, the most appropriate classification is Regulatory Filings (RNS), as it is a compliance document reporting share capital movements to the exchange.
2020-11-02 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares Classification · 100% confidence The document is a disclosure return related to changes in issued share capital and share buybacks by CMBC Capital Holdings Limited. It includes detailed information on share repurchases, issued shares, and confirmations that these transactions comply with listing rules. The document is structured as a regulatory disclosure form for equity issuers on the Hong Kong Stock Exchange, specifically a "Next Day Disclosure Return" for share capital changes and buybacks. It does not contain financial statements, management discussion, or earnings data, nor is it a report or presentation. It is a regulatory filing disclosing capital changes and share repurchase activity, fitting the category of Transaction in Own Shares (POS).
2020-11-02 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares Classification · 95% confidence The document is a Next Day Disclosure Return for a Main Board listed issuer, CMBC Capital Holdings Limited, detailing changes in issued share capital and share buybacks. It includes specific data on share repurchases, cancellations, and confirmations of compliance with listing rules. The content focuses on reporting share capital changes and repurchase activities rather than announcing a new report or providing financial results. The document is regulatory in nature, related to share capital changes and repurchases, fitting the category of Transaction in Own Shares (POS). The document length is 8373 characters, which is substantive and contains detailed transactional data, not just an announcement or certification. Therefore, the appropriate classification is POS with high confidence.
2020-10-30 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares Classification · 95% confidence The document is a Next Day Disclosure Return for a Main Board listed issuer, CMBC Capital Holdings Limited, detailing changes in issued share capital and share buybacks. It includes specific data on share repurchases, issued shares, and confirmations related to compliance with listing rules. The content focuses on reporting share capital changes and repurchase activities rather than announcing or presenting financial results or management commentary. This fits the definition of a Transaction in Own Shares (POS) filing, which reports company buybacks or sales of its own shares. The document length (8200 characters) and detailed transactional data support this classification rather than a brief announcement or a general regulatory filing.
2020-10-29 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares Classification · 95% confidence The document is a Next Day Disclosure Return for a Main Board listed issuer, CMBC Capital Holdings Limited, detailing changes in issued share capital and share buybacks. It includes specific data on share repurchases, dates, prices, and confirmations of compliance with listing rules. The content focuses on reporting share capital changes and repurchase activities rather than announcing a new share issue or capital restructuring event. This fits the description of a Transaction in Own Shares (POS) filing, which reports the company's buyback or sale of its own shares. The document is detailed and contains substantive data, not merely an announcement or certification, so it is not RPA or RNS. Therefore, the correct classification is POS with high confidence.
2020-10-28 English
NEXT DAY DISCLOSURE RETURN
Share Issue/Capital Change Classification · 95% confidence The document is a Next Day Disclosure Return for a Main Board listed issuer, CMBC Capital Holdings Limited, detailing changes in issued share capital and share buybacks. It includes specific data on share repurchases, issued shares, and confirmations related to compliance with listing rules. The content focuses on reporting share capital changes and repurchase activities, which aligns with announcements regarding share issues or capital changes. The document is not a full financial report, earnings release, or management discussion, but a regulatory disclosure about share capital changes and repurchases. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA). The document length (8200 characters) and detailed data support it being a substantive disclosure rather than a brief announcement or certification.
2020-10-27 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.